BB BIOTECH VENTURES is a healthcare-dedicated venture capital firm. We manage funds (limited partnerships) that invest in private companies developing and marketing drugs and medical devices or providing healthcare services. The Guernsey–based funds are advised by a team of senior venture capital professionals at Bellevue Asset Management AG (Kusnacht/Zurich, Switzerland).
The Bellevue Group has over 20 years of experience investing in healthcare companies and has raised and invested over $500mn in healthcare venture capital. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, hands-on experience, active networking, and deep sector knowledge with a focus on value creation.
